Morepen Laboratories Current Share Price | Morepen Laboratories Stock Screener
MOREPENLAB
Pharmaceuticals
Morepen Laboratories Current Stock Price Today
Live Share Price NSE
₹120.90
▲
0.34 (0.28%)
Live Share Price BSE
₹120.90
▲
0.25 (0.21%)
As of September 18, 2026, the live Morepen Laboratories share price (NSE: MOREPENLAB) is ₹120.90 on NSE and ₹120.90 on BSE, up 0.28% from the previous close, with shares trading between ₹118.14 and ₹123.45 in today's trading session, and a 52-week range of ₹33.68–₹120.90.
Browse MOREPENLAB balance sheet details to support your investment research.
Use the Morepen Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Morepen Laboratories Market Cap
₹6,286.67 Cr.
MOREPENLAB P/E Ratio (TTM)
41.34
Morepen Laboratories P/B Ratio
4.67
EPS (TTM)
₹1.73
Dividend Yield
0.19%
Debt to Equity
0.13
MOREPENLAB 52 Week High
₹120.90
Morepen Laboratories 52 Week Low
₹33.68
Operating Margin
14.00%
Profit Margin
9.74%
MOREPENLAB Revenue (TTM)
₹575.00
EBITDA
₹88.00
Net Income
₹56.00
Total Assets
₹1,936.00
Total Equity
₹1,247.00
Morepen Laboratories Current Share Price Chart
Track the current Morepen Laboratories share price and stock price with an interactive chart. Analyse MOREPENLAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete Morepen Laboratories stock quote in one place.
Morepen Laboratories Company Profile - Fundamental Screener
Screen Morepen Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MOREPENLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE083A01026
Morepen Laboratories Balance Sheet Screener
Screen MOREPENLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 1,936 | 1,778 | 1,293 | 1,111 | 1,070 | 858 | 664 | 615 | 586 | 538 |
| Current Assets | 1,164 | 1,159 | 889 | 756 | 734 | 527 | 372 | 300 | 243 | 192 |
| Fixed Assets | 513 | 489 | 307 | 267 | 252 | 225 | 216 | 236 | 264 | 272 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 199 | 91 | 44 | 37 | 36 | 30 | 28 | 23 | 20 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 1,247 | 1,187 | 847 | 752 | 578 | 424 | 284 | 253 | 226 | 196 |
| Share Capital | 110 | 110 | 102 | 102 | 96 | 90 | 90 | 90 | 90 | 90 |
| Reserves & Surplus | 1,137 | 1,047 | 745 | 651 | 457 | 291 | 194 | 163 | 136 | 106 |
Morepen Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Morepen Laboratories income statement and profit fundamentals.
Analyze MOREPENLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Morepen Laboratories share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 575 | 493 | 488 | 442 | 430 | 471 | 458 | 443 | 459 | 427 | 449 | 425 | 404 | 367 | 350 |
| Expenses | 488 | 460 | 438 | 381 | 401 | 424 | 417 | 394 | 404 | 375 | 394 | 388 | 375 | 348 | 328 |
| EBITDA | 88 | 33 | 50 | 61 | 29 | 47 | 42 | 49 | 55 | 53 | 55 | 37 | 29 | 19 | 22 |
| Operating Profit % | 14.00% | 5.00% | 10.00% | 7.00% | 6.00% | 9.00% | 8.00% | 10.00% | 11.00% | 11.00% | 11.00% | 8.00% | 7.00% | 4.00% | 6.00% |
| Depreciation | 8 | 6 | 10 | 11 | 9 | 17 | 5 | 2 | 6 | 10 | 8 | 8 | 8 | 7 | 7 |
| Interest | 5 | 4 | 4 | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 2 | 1 | 0 | 1 | 1 |
| Profit Before Tax | 75 | 23 | 35 | 46 | 16 | 26 | 35 | 46 | 48 | 42 | 44 | 29 | 21 | 11 | 14 |
| Tax | 18 | 8 | 8 | 5 | 4 | 5 | 9 | 11 | 12 | 14 | 12 | 7 | 6 | 3 | 5 |
| Net Profit | 56 | 16 | 28 | 41 | 11 | 20 | 27 | 35 | 36 | 29 | 32 | 21 | 15 | 8 | 9 |
| EPS | 1.03 | 0.28 | 0.50 | 0.75 | 0.20 | 0.35 | 0.49 | 0.65 | 0.71 | 0.54 | 0.63 | 0.42 | 0.29 | 0.16 | 0.15 |
Morepen Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen MOREPENLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 33 | 32 | 73 | -91 | -60 | 51 | 11 | 17 | 63 | 41 |
| Investing Activities | -126 | -322 | -83 | -47 | -32 | -70 | -13 | -13 | -27 | -14 |
| Financing Activities | 97 | 300 | 5 | 144 | 66 | 47 | 6 | 0 | -38 | -24 |
| Net Cash Flow | 4 | 10 | -5 | 6 | -26 | 28 | 4 | 4 | -1 | 3 |
Morepen Laboratories Shareholding Pattern Screener
See Morepen Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Morepen Laboratories promoter holding and ownership changes for MOREPENLAB on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 35.65% | 38.22% | 38.22% |
| FII Holding | 1.59% | 1.46% | 1.94% | 1.72% | 1.62% | 1.62% | 1.85% | 1.67% |
| DII Holding | 1.25% | 1.28% | 1.67% | 1.51% | 1.50% | 1.25% | 2.15% | 2.15% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 50.03% | 49.75% | 48.76% | 49.35% | 49.96% | 50.28% | 45.03% | 45.22% |
| Other Holding | 11.47% | 11.84% | 11.96% | 11.76% | 11.26% | 11.18% | 12.74% | 12.74% |
| Shareholder Count | 447,286 | 434,912 | 468,860 | 461,180 | 461,853 | 453,137 | 336,019 | 348,766 |
Morepen Laboratories Share Dividend Screener - Share Yield Analysis
Check Morepen Laboratories dividend history with payout and yield data.
View Morepen Laboratories dividend details including ex-dates and amounts for MOREPENLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.20 | 0.19% |
| 2025-March | ₹0.20 | 0.59% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Morepen Laboratories Stock Index Membership
See which indices include Morepen Laboratories stock.
Check MOREPENLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Morepen Laboratories Market Events Screener - Corporate Actions
Get Morepen Laboratories corporate actions including splits, bonuses, and buybacks.
Check Morepen Laboratories stock events that may affect MOREPENLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-26 | 2026-09-26 | Annual General Meeting | NA | 84.21% |
| 2026-09-18 | 2026-09-19 | Dividend | ₹ 0.20 /share | 142.91% |
| 2026-08-04 | 2026-08-04 | Quarterly Result Announcement | NA | 1.80% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 1.70% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 10.03% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -1.79% |
| 2025-09-06 | 2025-09-06 | Annual General Meeting | NA | -12.82% |
| 2025-08-29 | 2025-08-30 | Dividend | ₹ 0.20 /share | -17.00% |
| 2025-08-06 | 2025-08-06 | Quarterly Result Announcement | NA | -3.23% |
| 2025-05-12 | 2025-05-12 | Quarterly Result Announcement | NA | -5.11% |
| 2025-02-10 | 2025-02-10 | Extraordinary General Meeting | NA | -10.10% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 3.02% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | 1.20% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -9.94% |
| 2024-03-18 | 2024-03-18 | Extraordinary General Meeting | NA | -21.28% |
Morepen Laboratories Competitors Screener - Peer Comparison
Screen MOREPENLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 444,717 | 36.34 | 61,674 | 12.69% | 11,565 | 38.94 |
| Divis Laboratories | 243,116 | 83.41 | 11,067 | 13.95% | 2,568 | 57.81 |
| Torrent Pharmaceuticals | 183,052 | 85.57 | 13,886 | 20.34% | 2,138 | 42.03 |
| Zydus Life Science | 111,440 | 23.87 | 27,658 | 17.64% | 5,026 | 43.86 |
| Cipla | 109,705 | 32.76 | 29,045 | 2.24% | 3,870 | 35.04 |
| Laurus Labs | 102,870 | 95.29 | 6,868 | 22.01% | 890 | 56.63 |
| Dr Reddys Laboratories | 95,152 | 30.15 | 35,059 | 3.90% | 4,158 | 39.81 |
| Aurobindo Pharma | 94,535 | 25.82 | 34,145 | 5.56% | 3,503 | 49.75 |
| Lupin | 93,504 | 16.93 | 29,039 | 26.75% | 5,356 | 22.87 |
| Mankind Pharma | 92,759 | 45.72 | 14,636 | 14.85% | 1,938 | 34.16 |
Morepen Laboratories Company Announcements - News Screener
Screen MOREPENLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-10 | Announcement Under Regulation 30 Of The SEBI (LODR) | - |
| 2026-09-03 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-02 | Letter To The Members (No E-Mail Id Registered) Comprising Weblink Of The Annual Report: 2025-26 | - |
| 2026-09-02 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-09-02 | Notice Of 41St Annual General Meeting | - |
| 2026-09-02 | Reg. 34 (1) Annual Report. | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-08-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-08-04 | Intimation Of Annual General Meeting | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-04 | Intimation Of Record Date For Payment Of Final Dividend I.E. September 19 2026 | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-08-04 | Board Meeting Outcome for For Q1 FY 27 Financial Results | - |
| 2026-08-04 | Q1 FY 27 Financial Results | - |
| 2026-07-28 | Board Meeting Intimation for Q-1 FY27 Results | - |
| 2026-07-23 | Intimation Of Name Change Of Wholly Owned Subsidiary Company | - |
| 2026-07-06 | Announcement under Regulation 30 (LODR)-Change in Management | - |